‘Digiceuticals,’ new CGM devices, HbA1c alternatives transform diabetes management



CHICAGO — The growing abundance of technology options for better diabetes management and the trend away from HbA1c as the only evaluation metric for the condition are important parallel phenomena, according to a speaker at the Cardiometabolic Health Congress.
Anne Peters, MD, director of USC clinical diabetes programs and professor of clinical medicine at the Keck School of Medicine at the University of Southern California, said during a presentation that health care providers must not only acknowledge but seek to understand these trends in order to help improve diabetes care.
The idea



Source link

Leave a Reply!

So glad to see you sticking around!

Want to be the first one to receive the new stuff?

Enter your email address below and we'll send you the goodies straight to your inbox.

Thank You For Subscribing!

This means the world to me!

Spamming is not included! Pinky promise.